Five things for pharma marketers to know: Wednesday, August 9, 2017

Five things for pharma marketers to know: Wednesday, August 9, 2017

The FDA on pace for record generic drug approvals; CVS Health CEO doubts Amazon's entrance to pharmacy market; Sanofi to develop cancer immunotherapy

New ANA report finds 'transparency concerns' in production process

New ANA report finds 'transparency concerns' in production process

In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.

Drugmakers test out Tumblr, to tap specific audiences

Drugmakers test out Tumblr, to tap specific audiences

Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.

Healthcare agencies intensify college recruiting tactics

Healthcare agencies intensify college recruiting tactics

They are using social media campaigns, apprentice programs, and hands-on internships to recruit young, innovative talent right out of school.

Five things for pharma marketers to know: Tuesday, August 8, 2017

Five things for pharma marketers to know: Tuesday, August 8, 2017

A shorter list of risks in TV ads helps consumer comprehension; medical-school choice affects prescribing patterns; reps often show docs the same info

Pharma companies, now marketing high-science drugs, rely more on medical affairs

Pharma companies, now marketing high-science drugs, rely more on medical affairs

Five years ago, the notion of medical science liaisons as a guiding voice in the marketing mix was borderline preposterous. Now they're called upon early and often.

Lynn O'Connor Vos to leave ghg; Erin Byrne named CEO

Lynn O'Connor Vos to leave ghg; Erin Byrne named CEO

O'Connor Vos has served as CEO of the WPP Health & Wellness agency since 1994.

Allergan ramps up promotion for new rosacea drug

Allergan ramps up promotion for new rosacea drug

The drugmaker began advertising for Rhofade on Facebook in early August.

Five things for pharma marketers to know: Monday, August 7, 2017

Five things for pharma marketers to know: Monday, August 7, 2017

Insurers deny coverage of generic drugs; Teva to lay off 7,000 employees; Shkreli convicted of securities fraud

Roundtable: Market access takes center stage

Roundtable: Market access takes center stage

Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.

Five things for pharma marketers to know: Friday, August 4, 2017

Five things for pharma marketers to know: Friday, August 4, 2017

AbbVie's new HCV drug is cheaper than Gilead's Harvoni; Lilly's experimental migraine drugs beats placebo; Fitbit to launch smartwatch

Astellas promotes Moyra Knight to comms, corporate citizenship role

Astellas promotes Moyra Knight to comms, corporate citizenship role

She will also continue to serve as president of the Astellas U.S.A. Foundation.

Five things for pharma marketers to know: Thursday, August 3, 2017

Five things for pharma marketers to know: Thursday, August 3, 2017

FDA committee votes against J&J arthritis drug; scientists successfully edit genes; Shire mulls ADHD spin off

W2O's Twist hires new president

W2O's Twist hires new president

Former Edelman executive Mary Corcoran replaces Annalise Coady, who becomes president of W2O EMEA.

Johnson & Johnson is big winner in CVS diabetes formulary changes

Johnson & Johnson is big winner in CVS diabetes formulary changes

CVS Health will remove Lilly's Jardiance in favor of J&J's Invokana.

Five things for pharma marketers to know: Wednesday, August 2, 2017

Five things for pharma marketers to know: Wednesday, August 2, 2017

Celgene and Agios secure FDA approval for AML drug Idhifa; GSK hires chief digital and technology officer; Pfizer wants tax reform before M&A engagement

From diversity to pricing issues, BMS marketing chief strikes a balance

From diversity to pricing issues, BMS marketing chief strikes a balance

Susan Sweeney has earned a reputation for such pragmatism and attentiveness to the things that really matter.

Read the complete July 2017 digital edition

Read the complete July 2017 digital edition

Read the 2017 Agency Issue in its entirety.

Five things for pharma marketers to know: Tuesday, August 1, 2017

Five things for pharma marketers to know: Tuesday, August 1, 2017

Express Scripts removes 64 branded drugs from 2018 formulary; wearable market can regain momentum, analysts say; FDA accepts Herceptin biosimilars for review

Photo | The 2017 Hall of Femme

Photo | The 2017 Hall of Femme

Meet 13 of our 16 Hall of Femme honorees.

Five things for pharma marketers to know: Monday, July 31, 2017

Five things for pharma marketers to know: Monday, July 31, 2017

FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi

Drugmakers turn to tech to better demonstrate empathy

Drugmakers turn to tech to better demonstrate empathy

Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.

Cannabis nutrition company focuses on education

Cannabis nutrition company focuses on education

A particular focus is put on the emerging research about cannabis and its benefits for the human body.

Five things for pharma marketers to know: Friday, July 28, 2017

Five things for pharma marketers to know: Friday, July 28, 2017

Drugmakers inconsistently share clinical trial data; AstraZeneca's share price falls after Mystic results; some pregnancy apps share info with marketers

Gilead's educational campaign boosted HCV diagnosis rates for baby boomers

Gilead's educational campaign boosted HCV diagnosis rates for baby boomers

An unbranded campaign encouraging baby boomers to get tested for hepatitis C helped boost screening and diagnosis numbers, which in turn upped sales of its HCV therapies.

Neil Matheson leaves Huntsworth Health

Neil Matheson leaves Huntsworth Health

The CEO of Huntsworth's biggest and fastest-growing unit Huntsworth Health, which includes Nitrogen and Tonic Life, has departed after eight years.

Five things for pharma marketers to know: Thursday, July 27, 2017

Five things for pharma marketers to know: Thursday, July 27, 2017

Generic drugmakers reportedly seeking deals; GSK to refocus R&D; Merck and AstraZeneca to test combo cancer drug

Five things for pharma marketers to know: Wednesday, July 26, 2017

Five things for pharma marketers to know: Wednesday, July 26, 2017

Jury says AbbVie fraudulently misrepresented risks of AndroGel; Celgene settles False Claims Act lawsuit; Amgen reports more Repatha prescribers

Astellas promotes two sales veterans to new roles

Astellas promotes two sales veterans to new roles

David Musselman and Lynn Gerber are now leading sales for the company's primary care and specialty products.

Shutterstock says men are 'more responsive' to online ads

Shutterstock says men are 'more responsive' to online ads

Images that "mirror the demographic profile of their target audience" perform best, according to an eye-tracking study from picture provider Shutterstock.

Five things for pharma marketers to know: Tuesday, July 25, 2017

Five things for pharma marketers to know: Tuesday, July 25, 2017

Biogen reports better-than-expected Spinraza sales; FDA to discuss opioid prescriptions with payers; UnitedHealth Group launches media review

Cannes Lions revenues up 7% in 2017 despite delegate decline

Cannes Lions revenues up 7% in 2017 despite delegate decline

The 2017 Cannes Lions festival earned revenues of about $820 million for its owner Ascential, despite "slightly reduced" award entry and delegate numbers, the company's half-year results say.

Publicis taps Brandes as EVP of biz development

Publicis taps Brandes as EVP of biz development

He reports to Michelle Keefe, group president at Publicis Health.

Five things for pharma marketers to know: Monday, July 24, 2017

Five things for pharma marketers to know: Monday, July 24, 2017

Samsung Bioepis launches Remicade biosimilar; WHO encourages uses of generic version of Sovaldi; nearly 20 million people with HIV on treatment

WebMD sells to private equity firm KKR

WebMD sells to private equity firm KKR

The deal is worth roughly $2.8 billion.

Drugmakers face challenges marketing new heart drugs

Drugmakers face challenges marketing new heart drugs

Experts say this means drugmakers need to find new ways to communicate the value of their products.

Five things for pharma marketers to know: Friday, July 21, 2017

Five things for pharma marketers to know: Friday, July 21, 2017

The FDA to study whether linking to risk information affects patient recall; patients view docs who take industry payments as less honest; Mallinckrodt ups political donations

Populism and Creativity, Live from Cannes, Presented by McCann Health

Populism and Creativity, Live from Cannes, Presented by McCann Health

McCann Health, Cannes Lions Healthcare Network of the Year, hosted a roundtable to discuss the role of creativity in a new world order where populism is undermining trust.

Are you making as much money as your peers?

Are you making as much money as your peers?

The 2017 MM&M Career & Salary Survey is open. Fill it out, and tell us about the latest salary and career trends in the pharma and healthcare sectors.

Five things for pharma marketers to know: Thursday, July 20, 2017

Five things for pharma marketers to know: Thursday, July 20, 2017

About 4.4 billion prescriptions filled in the U.S. in 2016; Sanofi and Ablynx reach I-O deal; biotech M&A slows in H1

Diabetes drugmakers partner with mobile startups to boost patient engagement

Diabetes drugmakers partner with mobile startups to boost patient engagement

Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.

GE premiers Heroines of Health video documentary in bite-size form

GE premiers Heroines of Health video documentary in bite-size form

The healthcare company released the documentary in minute-long snippets over a month, then debuted the full film this week.

Five things for pharma marketers to know: Wednesday, July 19, 2017

Five things for pharma marketers to know: Wednesday, July 19, 2017

Cost of throwing out expired drugs is $800 million per year; the FDA approves Gilead's new HCV drug; CDC says 1 in 10 Americans have diabetes

A Pornhub pro offers sex ed for seniors

A Pornhub pro offers sex ed for seniors

The 15-minute short film covers condom use, STIs, and safer sex positions for bodies that have become less flexible.

Five things for pharma marketers to know: Tuesday, July 18, 2017

Five things for pharma marketers to know: Tuesday, July 18, 2017

Novartis raises Alcon forecast; UDG acquires Cambridge BioMarketing; Spark Therapeutics receives priority review for Luxturna gene therapy

Publicis Health: Privacy regs won't hamper Marcel's utility in pharma

Publicis Health: Privacy regs won't hamper Marcel's utility in pharma

Publicis Health CEO Nick Colucci talks to MM&M about whether the AI tool will get U.S. and European creative directors to collaborate.

One year later: How Pokémon Go leveled up AR for marketing

One year later: How Pokémon Go leveled up AR for marketing

The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.

Five things for pharma marketers to know: Monday, July 17, 2017

Five things for pharma marketers to know: Monday, July 17, 2017

More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign

Pharma spending on CME rose in 2016

Pharma spending on CME rose in 2016

It's the third year of consecutive growth for spending on accredited CME, according to the Accreditation Council for Continuing Medical Education.

Five things for pharma marketers to know: Friday, July 14, 2017

Five things for pharma marketers to know: Friday, July 14, 2017

The FDA approves J&J psoriasis drug; PARP inhibitors are not cost-effective, ICER says; Verily releases mosquitoes to combat Zika

Five things for pharma marketers to know: Thursday, July 13, 2017

Five things for pharma marketers to know: Thursday, July 13, 2017

AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge

Novartis' CAR-T therapy gets nod from FDA committee

Novartis' CAR-T therapy gets nod from FDA committee

The drugmaker is one step closer to a potential approval of its experimental cancer treatment.

Five things for pharma marketers to know: Wednesday, July 12, 2017

Five things for pharma marketers to know: Wednesday, July 12, 2017

Former sales reps for Insys plead guilty to kickback allegations; digital health funding on the rise; PhRMA launches campaign about drug costs

Stubborn politicians get flooded by women's health facts via fax

Stubborn politicians get flooded by women's health facts via fax

How Huge and the New York Civil Liberties Union used lawmakers' own antiquated ideas to support the Reproductive Health Act.

Five things for pharma marketers to know: Tuesday, July 11, 2017

Five things for pharma marketers to know: Tuesday, July 11, 2017

Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics

The 2017 MM&M Awards: The Shortlist

The 2017 MM&M Awards: The Shortlist

Find out who made award-winning work this year.

Otsuka's April Mitchell on leading versus managing

Otsuka's April Mitchell on leading versus managing

When you've figured out the difference, people will walk through fire for you, a mentor once told her.

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

Hijacked by shampoo or an increasingly relevant place for PR to shine? Experts dissect Lions Health

The relative dearth of Pharma entries, and the fact that Lions Health is very much a separate affair to the rest of the week are two factors for the Lions to keep an eye on.

Five things for pharma marketers to know: Monday, July 10, 2017

Five things for pharma marketers to know: Monday, July 10, 2017

Gottlieb calls for new opioid training for docs; FDA committee to examine Novartis' CAR-T therapy; no Viagra ads expected during NFL season

Ancestry's first work from Droga5 makes a bold statement about America's diversity

Ancestry's first work from Droga5 makes a bold statement about America's diversity

The genomics brand brings together 29 descendants of the founding fathers for an atypical July Fourth campaign.

Five things for pharma marketers to know: Friday, July 7, 2017

Five things for pharma marketers to know: Friday, July 7, 2017

Drug ads on mobile are not providing enough risk info; rare-disease drugmakers are concerned about healthcare bill; volume of opioid prescriptions drops

U.K.-based Fishawack Group acquires Carling Group, to bolster U.S. presence

U.K.-based Fishawack Group acquires Carling Group, to bolster U.S. presence

The acquisition is meant to add creative expertise to the medical communications group.

Five things for pharma marketers to know: Thursday, July 6, 2017

Five things for pharma marketers to know: Thursday, July 6, 2017

The FDA suspends three Keytruda studies; drug and device makers gave $8 billion in payments to providers in 2016; Opdivo beat Yervoy in skin-cancer trial

Five things for pharma marketers to know: Wednesday, July 5, 2017

Five things for pharma marketers to know: Wednesday, July 5, 2017

Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans

9 under the radar healthcare agencies to watch in 2017

9 under the radar healthcare agencies to watch in 2017

Here are nine agencies that are gaining traction in healthcare marketing.

MM&M's 2017 healthcare agency solar system

MM&M's 2017 healthcare agency solar system

Discover how M&A activity in 2016 and 2017 has reshaped North American healthcare agencies and the holding companies that own them.

The MM&M Agency Issue | The archives

The MM&M Agency Issue | The archives

Here you'll find the last four years of the MM&M Agency Issue.

Agencies embrace health, in bid to diversify beyond pharma

Agencies embrace health, in bid to diversify beyond pharma

Healthcare networks instigated a broad set of changes in a grand embrace of non-pharma business that diversified revenue streams and took specialist agencies out of their comfort zones.

The top 100 healthcare agencies, ranked by 2016 revenue

The top 100 healthcare agencies, ranked by 2016 revenue

Havas Health & You, WPP Health & Wellness, and Klick Health reported the highest revenue last year.

Questions for 5 of the healthcare agency world's top execs

Questions for 5 of the healthcare agency world's top execs

The CEOs of the industry's largest holding companies discuss how they're reasserting their businesses.

MM&M's 2017 Agency Issue

MM&M's 2017 Agency Issue

Read on for more about the top performing firms, the trends shaping the business, and the story behind each of the top 100 agencies.

Five things for pharma marketers to know: Friday, June 30, 2017

Five things for pharma marketers to know: Friday, June 30, 2017

The FDA plans to review orphan drug backlog; drugmaker supported charity helped patients pay for donor's drugs; low dose Xarelto gets Priority Review

Five things for pharma marketers to know: Thursday, June 29, 2017

Five things for pharma marketers to know: Thursday, June 29, 2017

Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition

Johnson & Johnson CMO: Innovation needs to sit outside the bottle

Johnson & Johnson CMO: Innovation needs to sit outside the bottle

Alison Lewis, the global chief marketing officer of Johnson & Johnson consumer division, has little appetite for new flavours and variants but instead wants to rethink innovation as a means to solve consumer problems.

Five things for pharma marketers to know: Wednesday, June 28, 2017

Five things for pharma marketers to know: Wednesday, June 28, 2017

Lawmakers delay healthcare bill vote; Merck affected by cyberattack; more young people are having strokes

Merck, Novartis pipeline stunners headline surprisingly good month for CV agents

Merck, Novartis pipeline stunners headline surprisingly good month for CV agents

Merck's CETP inhibitor anacetrapib and Novartis' monoclonal antibody ACZ885 hit their primary goals in late-stage cardiovascular outcomes trials, both unexpectedly positive results that are heating up this category.

Read the complete Patient Journey 2017 digital edition

Read the complete Patient Journey 2017 digital edition

Here you'll find everything from the Patient Journey 2017 supplement to our June issue.

Read the complete June 2017 digital edition

Read the complete June 2017 digital edition

Here you'll find everything from our June 2017 issue, including our Pharma Report, our Hall of Femme, and two roundtable discussions on media and oncology.

Pfizer celebrates the faces behind its vaccines with documentary

Pfizer celebrates the faces behind its vaccines with documentary

The video is part of Pfizer's ongoing corporate ad campaign Before it Became a Medicine.

Five things for pharma marketers to know: Tuesday, June 27, 2017

Five things for pharma marketers to know: Tuesday, June 27, 2017

Merck announces positive trial results for CETP inhibitor; Purdue Pharma defends withholding of OxyContin marketing material; Roche's experimental haemophilia drug significantly cuts bleed rate

LiquidHub acquires Eveo to form new health offering

LiquidHub acquires Eveo to form new health offering

The agency founded by Olivier Zitoun in 1999 has been snapped up as part of LiquidHub's push to offer multi-disciplinary capabilities.

Standing out in crowded cancer market

Standing out in crowded cancer market

Opdivo's marketing campaigns need to both market to and educate consumers about the new immunotherapy cancer treatment.

Five things for pharma marketers to know: Monday, June 26, 2017

Five things for pharma marketers to know: Monday, June 26, 2017

The performance of generic drugs is not always guaranteed; the FDA approves a new blood thinner; Gottlieb wants rejection letters public

PulseCX promotes David Zaritsky to CEO

PulseCX promotes David Zaritsky to CEO

Zaritsky succeeds Jay Bolling, who becomes executive chairman

Five things for pharma marketers to know: Friday, June 23, 2017

Five things for pharma marketers to know: Friday, June 23, 2017

Novartis drug prevents heart attacks and strokes, per trial; Senate lawmakers unveil healthcare bill; Pfizer receives CRL for Epogen biosimilar

Five things for pharma marketers to know: Thursday, June 22, 2017

Five things for pharma marketers to know: Thursday, June 22, 2017

The FDA plans public meeting to encourage generic competition; Mylan reportedly offered rebates to six Medicaid programs; Republicans to present draft bill for Obamacare replacement

The FDA attempts to understand how disclosures affect drug ads

The FDA attempts to understand how disclosures affect drug ads

The FDA recently proposed studies designed to determine how disclosures in drug ads affect how viewers frame information.

Five things for pharma marketers to know: Wednesday, June 21, 2017

Five things for pharma marketers to know: Wednesday, June 21, 2017

Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections

How Zicam made the most of TV's cold season

How Zicam made the most of TV's cold season

How Zicam proved that there is a better, more data-driven approach to buying and measuring TV advertising..

Allergan reaches the masses via unbranded Botox Facebook page

Allergan reaches the masses via unbranded Botox Facebook page

In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.

Area 23's Healthcare Agency of the Year win was four years in the making

Area 23's Healthcare Agency of the Year win was four years in the making

The FCB Health network won big this year with several campaigns, including work featuring a bra that detects breast cancer and an awareness campaign for human trafficking.

Five things for pharma marketers to know: Tuesday, June 20, 2017

Five things for pharma marketers to know: Tuesday, June 20, 2017

Novartis reports positive Phase-III results for Eylea competitor; AZ faces "critical transition point" in MYSTIC trial; physician shortage expected to rise

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers must take the lead on opioid epidemic comms, say experts

Drugmakers are increasingly facing blame from regulators, lawmakers, and the public as the list of lawsuits and investigations at the state and local levels grows.

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Under siege from intense competition and the rise of value-based contracts, diabetes drugmakers look to outcomes data to stand out.

Five things for pharma marketers to know: Monday, June 19, 2017

Five things for pharma marketers to know: Monday, June 19, 2017

Adamis receives FDA approval for EpiPen rival Symjepi; Clovis reports positive trial results for ovarian cancer drug Rubraca; hedge fund billionaire John Paulson joins Valeant board of directors

Day 2 at Lions Health: Watson's got its eye on you, Cannes

Day 2 at Lions Health: Watson's got its eye on you, Cannes

There's much for marketers to glean from stepping into different environments, working with new partners, and putting assets to work in new ways, said one speaker.

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

Day 1 at Lions Health: Use the data, stay persistent, and avoid being 'innovative'

If there is one thing to take away from the opening day at the Cannes Lions International Festival of Creativity, it is this. Find the talks that inspire you, and then find the places with AC.

Lions Health: The 2017 health and wellness winners

Lions Health: The 2017 health and wellness winners

An Australian road safety campaign caught the eyes of the judges.

Lions Health: The 2017 pharma winners

Lions Health: The 2017 pharma winners

A public health campaign developed by McCann Health India for children in Afghanistan was the big winner in 2017.